Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


30.12.2018

2 Ann Thorac Surg
2 Anticancer Res
1 BMC Cancer
1 BMJ
1 Cancer
2 Cancer Lett
1 Cancer Res
1 Carcinogenesis
4 Clin Lung Cancer
1 Clin Nucl Med
1 Eur J Cardiothorac Surg
2 Eur Respir J
1 J Clin Invest
1 J Natl Cancer Inst
1 J Surg Oncol
2 J Thorac Oncol
1 JAMA Oncol
2 Oncol Rep
2 Oncologist
1 PLoS Comput Biol
1 PLoS One
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. NOMORI H, Mori T, Shiraishi A, Fujino K, et al
    Long-term prognosis after segment ectomy for cT1N0M0 non-small cell lung cancer.
    Ann Thorac Surg. 2018 Dec 20. pii: S0003-4975(18)31846.
    PubMed     Text format     Abstract available

  2. TRAN B, Sedrakyan A, Flynn P, Altorki N, et al
    Re-intervention and survival after limited lung resection for lung cancer treatment in Australia.
    Ann Thorac Surg. 2018 Dec 20. pii: S0003-4975(18)31845.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. WADA K, Kishi N, Kanayama N, Hirata T, et al
    Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy.
    Anticancer Res. 2019;39:491-497.
    PubMed     Text format     Abstract available

  4. KUO WI, Cheng KH, Chang YJ, Wu TT, et al
    Radiolabeling, Characteristics and NanoSPECT/CT Imaging of 188Re-cetuximab in NCI-H292 Human Lung Cancer Xenografts.
    Anticancer Res. 2019;39:183-190.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. GUO HQ, Jia J, Zhao LL, Zhao H, et al
    Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non-small-cell lung cancer.
    BMC Cancer. 2018;18:1277.
    PubMed     Text format     Abstract available


    BMJ

  6. BOWDEN J, Fenning S, Marron B, Macpherson C, et al
    Best supportive care in advanced lung cancer-more than a label?
    BMJ. 2018;363:k5017.
    PubMed     Text format    


    Cancer

  7. PRINTZ C
    Currently recommended lung cancer screening guidelines may be insufficient for high-risk minorities.
    Cancer. 2019;125:10-11.
    PubMed     Text format    


    Cancer Lett

  8. PARK JH, Jung KH, Kim SJ, Yoon YC, et al
    HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30721.
    PubMed     Text format     Abstract available

  9. WU Z, Fournel L, Stadler N, Liu J, et al
    Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by Neurotensin antibody.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30722.
    PubMed     Text format     Abstract available


    Cancer Res

  10. PHALLEN J, Leal A, Woodward BD, Forde PM, et al
    Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer.
    Cancer Res. 2018 Dec 20. pii: 0008-5472.CAN-18-1082.
    PubMed     Text format     Abstract available


    Carcinogenesis

  11. DAI J, Li Z, Amos CI, Hung RJ, et al
    Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.
    Carcinogenesis. 2018 Dec 24. pii: 5259175. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  12. SAKAMOTO MR, Honce JM, Lindquist DL, Camidge DR, et al
    Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30306.
    PubMed     Text format    

  13. RAZ DJ, Wu G, Nelson RA, Sun V, et al
    Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program.
    Clin Lung Cancer. 2019;20:e115-e122.
    PubMed     Text format     Abstract available

  14. JIANG T, Zhao J, Zhao C, Li X, et al
    Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Dec 4. pii: S1525-7304(18)30310.
    PubMed     Text format     Abstract available

  15. KWON YJ, You NY, Lee JW, Kim J, et al
    High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service-Health Screening Cohort.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30305.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  16. LECCISOTTI L, Lorusso M, Giannetta E, Isidori AM, et al
    68Ga-DOTATOC PET/CT in Thyroid Metastases of Lung Carcinoid.
    Clin Nucl Med. 2018 Oct 23. doi: 10.1097/RLU.0000000000002331.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  17. TANAKA S, Sugimoto S, Soh J, Oto T, et al
    Long-term outcomes of pneumonectomy, back-table lung preservation, double-sleeve resection and reimplantation for advanced central lung cancer: the Oto procedure.
    Eur J Cardiothorac Surg. 2018 Dec 24. pii: 5259358. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  18. LU J, Zhong H, Chu T, Zhang X, et al
    Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for non-small cell lung cancer therapy.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01562-2018.
    PubMed     Text format     Abstract available

  19. CROMBAG LMM, Dooms C, Stigt JA, Tournoy KG, et al
    Systematic and combined endosonographic staging of lung cancer (SCORE Study).
    Eur Respir J. 2018 Dec 21. pii: 13993003.00800-2018.
    PubMed     Text format     Abstract available


    J Clin Invest

  20. CHABANON RM, Muirhead G, Krastev DB, Adam J, et al
    PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
    J Clin Invest. 2018 Dec 27. pii: 123319. doi: 10.1172/JCI123319.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  21. KEHL KL, Lathan CS, Johnson BE, Schrag D, et al
    Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer.
    J Natl Cancer Inst. 2018 Dec 20. pii: 5255663. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  22. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
    Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  23. LEE YL, Hsu JF, Yang CJ
    Tracheoesophageal Fistula in a Patient with Advanced Non-Small Cell Lung Cancer Who Received Chemoradiotherapy and Ramucirumab.
    J Thorac Oncol. 2019;14:e17-e18.
    PubMed     Text format    

  24. VAN LOON J, Dingemans AC
    Is Concurrent Chemoradiotherapy Also the Best Treatment for Elderly Patients with Limited-Stage Small Cell Lung Cancer? - What the CONVERT Data Can Tell Us.
    J Thorac Oncol. 2019;14:13-15.
    PubMed     Text format    


    JAMA Oncol

  25. TOI Y, Sugawara S, Sugisaka J, Ono H, et al
    Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
    JAMA Oncol. 2018 Dec 27. pii: 2718925. doi: 10.1001/jamaoncol.2018.5860.
    PubMed     Text format     Abstract available


    Oncol Rep

  26. HUANG T, Zhang H, Wang X, Xu L, et al
    Gambogenic acid inhibits the proliferation of smallcell lung cancer cells by arresting the cell cycle and inducing apoptosis.
    Oncol Rep. 2018 Dec 21. doi: 10.3892/or.2018.6950.
    PubMed     Text format     Abstract available

  27. KAOWINN S, Kaewpiboon C, Koh SS, Kramer OH, et al
    STAT1HDAC4 signaling induces epithelialmesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2.
    Oncol Rep. 2018;40:2619-2627.
    PubMed     Text format     Abstract available


    Oncologist

  28. KHOZIN S, Carson KR, Zhi J, Tucker M, et al
    Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.
    Oncologist. 2018 Dec 27. pii: theoncologist.2018-0307.
    PubMed     Text format     Abstract available

  29. YOSHIMURA A, Chihara Y, Date K, Tamiya N, et al
    A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer.
    Oncologist. 2018 Dec 21. pii: theoncologist.2018-0858.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  30. CHEN X, Yin J, Qu J, Huang L, et al
    MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction.
    PLoS Comput Biol. 2018;14:e1006418.
    PubMed     Text format     Abstract available


    PLoS One


  31. Correction: Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice.
    PLoS One. 2018;13:e0210108.
    PubMed     Text format     Abstract available


    Thorax

  32. WALTER JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, et al
    Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Thorax. 2018 Dec 27. pii: thoraxjnl-2018-212152.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: